Research reveals new insights into a key antibiotic target in the fight against TB

June 30, 2015, University of Sussex
Research reveals new insights into a key antibiotic target in the fight against TB
Full Mycobacterium tuberculosis infection (Pulmonary Tuberculosis) Credit: stockdevil

Scientists at the University of Sussex have unraveled a key process in the bacterium that causes tuberculosis (TB), potentially paving the way for new antibiotics to fight the disease. 

TB is one of the world's top infectious killers, causing 1.5 million deaths every year. The TB bacterium Mycobacterium (Mtb) is estimated to be present in up to a third of the world's population, although active TB only develops in around one in 10 cases. 

While TB is curable, is on the rise and so a major challenge for scientists is to continually develop to treat the disease. 

Now an international effort involving scientists at Sussex and the Rockefeller University in New York has revealed that the key process in Mtb cells of reading the information contained in DNA differs from that in most other bacteria. Their findings are published in the journal Proceedings of the National Academy of Sciences

The process is called transcription and is conducted by an enzyme, called RNA polymerase, which uses a protein called sigma to bind with parts of the DNA. 

But researchers have now observed for the first time how, in Mtb, a second protein, called RbpA, helps in this process by binding to different parts of the DNA. 

Lead researcher, Dr Mark Paget, said: "Up until recently, we've always thought that RNA polymerase, whether it's in one bacterium or another, is pretty much identical. We now know that Mtb uses this additional protein and exactly what role it plays in transcription". 

RNA polymerase is one of the few proven targets for antibiotics in this organism, so this new finding should help in the testing of potential new drugs that inhibit RNA polymerase under laboratory conditions. This speeds up the drug discovery process by allowing scientists to quickly rule out treatments that do not work. 

Explore further: Tuberculosis avoids and subverts host immunity

More information: "Structural, functional, and genetic analyses of the actinobacterial transcription factor RbpA" PNAS 2015 112 (23) 7171-7176; published ahead of print May 26, 2015, DOI: 10.1073/pnas.1504942112

Related Stories

Tuberculosis avoids and subverts host immunity

December 23, 2014
An ancient disease, tuberculosis (TB) continues to be one of the major causes of disability and death worldwide. The recent TB cases in Quebec among the Inuit community has underscored the need to find new avenues to eradicate ...

New test could identify resistant tuberculosis faster

May 13, 2015
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers ...

Anti-diabetic drug springs new hope for tuberculosis patients

December 17, 2014
A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

Researchers discover potential treatment for drug-resistant tuberculosis

February 20, 2015
Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. ...

How RNA machinery navigates our genomic obstacle course

April 24, 2015
Once upon a time, scientists thought RNA polymerase—the molecule that kicks off protein synthesis by transcribing DNA into RNA—worked like a wind-up toy: Set it down at a start site in our DNA and it would whir steadily ...

New weapons against multidrug resistance in tuberculosis

October 8, 2014
Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.